Bruker (BRKR) Other Accumulated Expenses (2010 - 2026)

Bruker (BRKR) has 17 years of Other Accumulated Expenses data on file, last reported at $597.9 million in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses rose 1.0% year-over-year to $597.9 million; the trailing twelve-month figure through Mar 2026 stood at $597.9 million (up 1.0% YoY), and the FY2025 full-year result was $605.4 million, up 1062.0% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $597.9 million, down from $605.4 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $605.4 million in Q4 2025 and bottomed at $4.3 million in Q4 2023.
• The 5-year median for Other Accumulated Expenses is $493.6 million (2022), against an average of $424.9 million.
• The widest annual swing landed in 2023, when Other Accumulated Expenses slumped 89.76%; it then soared 1111.63% in 2024.
• A 5-year view of Other Accumulated Expenses shows it stood at $42.0 million in 2022, then plunged by 89.76% to $4.3 million in 2023, then jumped by 1111.63% to $52.1 million in 2024, then soared by 1062.0% to $605.4 million in 2025, then declined by 1.24% to $597.9 million in 2026.
• The last three Other Accumulated Expenses figures came in at $597.9 million (Q1 2026), $605.4 million (Q4 2025), and $604.0 million (Q3 2025), per Business Quant data.

Peer Comparison